This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

trusted source

proofread

Racial disparities in US drug overdose fatalities significantly higher in 2020, shows study

Racial disparities in US drug overdose fatalities significantly higher in 2020
Nationwide gender and race stratified crude rate trends for synthetic opioids (fentanyl, T40.4), psychostimulants with abuse potential (methamphetamines, T43.6), semi-synthetic opioids (prescription opioids, T40) and heroin (T40.1). Solid lines in the upper three rows represent the 2013–2019 quadratic regression; dotted lines correspond to values above and below the regression by three times the standard deviation calculated from 2013–2019 data; the open circle is the 2020 projection. Top row: results are stratified by gender. Note the increasing 2013–2019 trend and the 2020 value exceeding projections for fentanyl (T40.4) and methamphetamines (T43.6) for both genders; crude rates for prescription opioids (T40.2) and heroin (T40.1) have been decreasing but rose again in 2020, with significant rises especially in prescription opioids (T40.2) for both genders. Second (third) row from top: results are stratified by race for males (females). For fentanyl and heroin the Black male crude rate surpassed that of whites in 2018. Last row: Male-to-female ratio for all races. The ratio for Blacks is higher than the ratio for whites in all categories except for prescription opioids (T40.2). We include results for Asians in years when data is available; although crude rates are the lowest in the nation, this is the race with the largest male-to-female ratio in all drug categories. Credit: PLOS Global Public Health (2023). DOI: 10.1371/journal.pgph.0000769

The first year of the COVID pandemic saw significant increases in drug overdose deaths across the U.S., with rates higher than recent trends could have predicted.

Research published in PLOS Global Public Health reports trends in drug deaths between 2013 and 2020 across four major drug categories by gender, race and geography. It finds high levels of heterogeneity in overdose patterns across different demographic groups and that the gap in overdose fatalities between Black and white individuals continues to widen. Drug prevention and mitigation campaigns should therefore be tailored to specific at-risk groups.

Drug overdose deaths have been increasing in the U.S. for the past two decades. Since 2013 a "third wave" of overdose fatalities has arisen, with a shift from prescription opioids and towards synthetic ones, in particular illicit fentanyl. Researchers from UCLA, the California State University at Northridge, and the Frankfurt School of Finance and Management, used the National Vital Statistics System multiple cause-of-death mortality files, extracting rates by race and gender in all 50 states plus the District of Columbia. Profs. Maria R. D'Orsogna, Lucas Böttcher and Tom Chou considered the impact of four main drug categories of psychostimulants with addiction potential such as methamphetamines; heroin; prescription opioids, and synthetic such as fentanyl and its derivatives.

They found significant increases in overdose deaths from all categories except heroin in 2020, with data surpassing predictions derived from 2013-2019 trends. Rates among Black individuals of both genders exceeded those for white individuals for fentanyl and psychostimulants starting in 2018; the gap continued to widen in the years since. The largest 2020 rate is for Black males in the District of Columbia due to fentanyl with a rate almost 10 times higher than that for white males.

The authors believe that pandemic-related anxieties and a greater availability of cheaper drugs that may be easily ordered online contributed to the rise in fatal overdoses. They argue that drug prevention strategies should include racial, geographical and gender-specific efforts to better identify and serve at-risk groups.

Dr. D'Orsogna says, "The third wave of began in 2013 with the arrival of fentanyl on the illicit drug market. Although overdose deaths have steadily increased since then, the pandemic year 2020 saw a significant rise of fatalities in many states."

Dr. Böttcher adds, "Perhaps most surprising to us were the results for the District of Columbia. Here, the 2020 -induced mortality was 134 deaths per 100,000 Black male residents but only 14 deaths per 100,000 white male residents. These disparities existed even prior to the pandemic, and are seen in other states as well, such as Illinois or Missouri."

Dr. Chou notes, "To effectively combat the epidemic, given the large heterogeneity of fatality rates, it is essential that we conduct more local-level studies and better understand the unique needs of specific groups, as well as the ways in which culture, socio-economic factors, and geographic conditions influence substance use."

More information: Maria R. D'Orsogna et al, Fentanyl-driven acceleration of racial, gender and geographical disparities in drug overdose deaths in the United States, PLOS Global Public Health (2023). DOI: 10.1371/journal.pgph.0000769

Journal information: PLOS Global Public Health
Citation: Racial disparities in US drug overdose fatalities significantly higher in 2020, shows study (2023, March 22) retrieved 25 April 2024 from https://medicalxpress.com/news/2023-03-racial-disparities-drug-overdose-fatalities.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Increase in overdose mortality greater among the pregnant in 2020

10 shares

Feedback to editors